EX-99.9 2 d539653dex999.htm EX-99.9 EX-99.9

Exhibit 99.9

JOINT FILING AGREEMENT

THIS JOINT FILING AGREEMENT is entered into as of May 15, 2013, by and among the parties hereto. The undersigned hereby agree that the Statement on the amendment to the Schedule 13D with respect to the common stock, par value $0.0001 per share (the “Common Stock”) of China Biologic Products, Inc., to which this agreement is attached as an exhibit, and any amendment thereafter signed by each of the undersigned shall be (unless otherwise determined by the undersigned) filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.

 

Dated: May 15, 2013   WP X Biologics LLC
 

By: Warburg Pincus Private Equity X, L.P., its managing member

By: Warburg Pincus X, L.P., its general partner

  By: Warburg Pincus X LLC, its general partner
  By: Warburg Pincus Partners LLC, its sole member
  By: Warburg Pincus & Co., its managing member
  By:  

/s/ Scott A. Arenare

    Name:   Scott A. Arenare
    Title:   Attorney-in-Fact*
  WARBURG PINCUS PRIVATE EQUITY X, L.P.
  By: Warburg Pincus X, L.P., its general partner
  By: Warburg Pincus X LLC, its general partner
  By: Warburg Pincus Partners LLC, its sole member
  By: Warburg Pincus & Co., its managing member
  By:  

/s/ Scott A. Arenare

    Name:   Scott A. Arenare
    Title:   Attorney-in-Fact*
  WARBURG PINCUS X PARTNERS, L.P.
  By: Warburg Pincus X, L.P., its general partner
  By: Warburg Pincus X LLC, its general partner
  By: Warburg Pincus Partners LLC, its sole member
  By: Warburg Pincus & Co., its managing member
  By:  

/s/ Scott A. Arenare

    Name:   Scott A. Arenare
    Title:   Attorney-in-Fact*

 

-1-


  WARBURG PINCUS X, L.P.
  By: Warburg Pincus X LLC, its general partner
  By: Warburg Pincus Partners LLC, its sole member
  By: Warburg Pincus & Co., its managing member
  By:  

/s/ Scott A. Arenare

    Name:   Scott A. Arenare
    Title:   Attorney-in-Fact*
  WARBURG PINCUS X LLC
  By: Warburg Pincus Partners LLC, its sole member
  By: Warburg Pincus & Co., its managing member
  By:  

/s/ Scott A. Arenare

    Name:   Scott A. Arenare
    Title:   Attorney-in-Fact*
  WARBURG PINCUS PARTNERS LLC
  By: Warburg Pincus & Co., its managing member
  By:  

/s/ Scott A. Arenare

    Name:   Scott A. Arenare
    Title:   Attorney-in-Fact*
  WARBURG PINCUS & CO.
  By:  

/s/ Scott A. Arenare

    Name:   Scott A. Arenare
    Title:   Attorney-in-Fact*
  WARBURG PINCUS LLC
  By:  

/s/ Scott A. Arenare

    Name:   Scott A. Arenare
    Title:   Managing Director

 

-2-


  CHARLES R. KAYE
  By:  

/s/ Charles R. Kaye

    Name:   Charles R. Kaye
    By:   Scott A. Arenare, Attorney-in-Fact*
  JOSEPH P. LANDY
  By:  

/s/ Joseph P. Landy

    Name:   Joseph P. Landy
    By:   Scott A. Arenare, Attorney-in-Fact*

 

* The Power of Attorney given by each of Warburg Pincus & Co., Mr. Kaye and Mr. Landy was previously filed with the U.S. Securities & Exchange Commission on January 15, 2013 as an exhibit to a statement on Schedule 13D/A filed by Warburg Pincus Private Equity X, L.P. with respect to Talon Therapeutics, Inc. and is hereby incorporated by reference.

 

-3-